| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8735407 | Hepatobiliary & Pancreatic Diseases International | 2017 | 7 Pages |
Abstract
IL-2, IL-18 and IFN-γ were from liver and might serve as biomarkers for monitoring GVHD development and the effects of anti-GVHD treatment. Granzyme B and perforin may play a role in increasing IL-2, IL-18, and IFN-γ levels in GVHD patients.
Related Topics
Health Sciences
Medicine and Dentistry
Hepatology
Authors
Xue-Qin Meng, Xin-Hua Chen, Zayd Sahebally, Yu-Ning Xu, Sheng-Yong Yin, Li-Ming Wu, Shu-Sen Zheng,